Strengths
The Castleman Disease Collaborative Network (CDCN) has a patient-centered approach, ensuring that the needs and experiences of patients with Castleman disease are prioritized in research and treatment.
CDCN employs innovative research strategies, including a unique crowdsourcing model that allows patients and researchers to identify and prioritize research questions.
The organization has established a strong network of global experts, facilitating collaboration that accelerates research and treatment advancements.
CDCN's co-founder is a patient, which adds a personal and urgent perspective to the organization's mission, enhancing its credibility and relatability.
The organization has demonstrated rapid progress in research and treatment, achieving in one year what typically takes a decade in traditional biomedical research.
CDCN provides comprehensive support for patients and their loved ones, including resources, community engagement, and opportunities for involvement in research.
The organization is positioned as a leader in the fight against Castleman disease, differentiating itself through its innovative approach and commitment to patient involvement.
CDCN's focus on drug repurposing for Castleman disease opens new avenues for treatment, potentially leading to faster and more effective therapeutic options.